Virulence genotype and phenotype of two clinical isolates of Arcobacter butzleri obtained from patients with different pathologies.

Antimicrobial resistance Arcobacter butzleri Caco-2 infection Comparative genomics Virulence

Journal

Archives of microbiology
ISSN: 1432-072X
Titre abrégé: Arch Microbiol
Pays: Germany
ID NLM: 0410427

Informations de publication

Date de publication:
04 Nov 2023
Historique:
received: 23 08 2023
accepted: 13 10 2023
revised: 28 09 2023
medline: 6 11 2023
pubmed: 4 11 2023
entrez: 4 11 2023
Statut: epublish

Résumé

The surge in human arcobacteriosis has increased interest in determining the mechanisms involved in the pathogenesis of Arcobacter butzleri. Here, genomic analyses and in vitro Caco-2 infection, motility, urease and antimicrobial susceptibility testing (AST) assays were used to characterise the virulence and antimicrobial resistance (AMR) determinants of strains HC-1, isolated from a patient with travellers' diarrhoea, and HC-2, isolated from another with pruritus. AMR determinants conferring resistance to tetracycline (tetO, present in both genomes) and to ampicillin and amoxicillin-clavulanic acid (bla3, present in HC-2) were identified. The same determinants associated with flagellum, chemotaxis, adhesion and invasion were detected in both, but HC-1 lacked eight flagellar genes. The urease cluster was only present in HC-1. Motility and urease tests confirmed the genetic differences between strains, but no genetic marker related to the inability of HC-2 to adhere and invade was identified. This inability could be conditioning the patient's pathology.

Identifiants

pubmed: 37923944
doi: 10.1007/s00203-023-03709-3
pii: 10.1007/s00203-023-03709-3
pmc: PMC10624747
doi:

Substances chimiques

Urease EC 3.5.1.5
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

369

Subventions

Organisme : Eusko Jaurlaritza
ID : PA20/03
Organisme : Euskal Herriko Unibertsitatea
ID : GIU21/021

Informations de copyright

© 2023. The Author(s).

Références

Genomics. 2021 Jul;113(4):2065-2076
pubmed: 33961980
Biochim Biophys Acta. 2010 Apr;1804(4):755-61
pubmed: 19948254
Int J Med Microbiol. 2002 Mar;291(8):605-14
pubmed: 12008914
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0173621
pubmed: 34748382
BMC Microbiol. 2009 Sep 14;9:196
pubmed: 19751525
Methods Mol Biol. 2009;537:39-64
pubmed: 19378139
BMC Microbiol. 2014 Jul 11;14:185
pubmed: 25012600
Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Mar Pollut Bull. 2008 Mar;56(3):600-6
pubmed: 18215401
Antimicrob Agents Chemother. 2014;58(1):212-20
pubmed: 24145532
J Bacteriol. 2001 Oct;183(20):5803-12
pubmed: 11566977
Front Microbiol. 2022 Dec 01;13:1004224
pubmed: 36532418
J Bacteriol. 2008 Nov;190(21):7298-301
pubmed: 18708495
J Food Prot. 2014 Jun;77(6):880-4
pubmed: 24853508
Infect Genet Evol. 2020 Jun;80:104213
pubmed: 32006709
Front Microbiol. 2019 Apr 16;10:670
pubmed: 31057492
J Bacteriol. 2009 Apr;191(8):2530-40
pubmed: 19201794
BMC Microbiol. 2019 Jan 11;19(1):11
pubmed: 30634926
Sci Rep. 2018 Sep 24;8(1):14307
pubmed: 30250171
Microbiol Spectr. 2022 Aug 31;10(4):e0100322
pubmed: 35862990
Compr Rev Food Sci Food Saf. 2020 Jul;19(4):2071-2109
pubmed: 33337088
Front Cell Infect Microbiol. 2023 Jan 25;13:1094067
pubmed: 36761899
Antimicrob Agents Chemother. 1989 Dec;33(12):2042-8
pubmed: 2694948
Infect Dis Now. 2021 Sep;51(6):564-566
pubmed: 34486524
Commun Biol. 2021 Nov 16;4(1):1291
pubmed: 34785766
FEMS Immunol Med Microbiol. 2007 Jun;50(1):51-8
pubmed: 17343682
J Clin Microbiol. 2015 Apr;53(4):1448-51
pubmed: 25673792
Antimicrob Agents Chemother. 2000 Dec;44(12):3322-7
pubmed: 11083635
J Infect Dis. 2009 Sep 1;200(5):756-64
pubmed: 19604116
Int J Med Microbiol. 2010 Apr;300(4):205-11
pubmed: 19665925
FEMS Immunol Med Microbiol. 2008 Jun;53(1):85-95
pubmed: 18400014
Mol Microbiol. 1993 Jan;7(1):69-79
pubmed: 8094880
Curr Protoc Bioinformatics. 2020 Jun;70(1):e102
pubmed: 32559359
Int J Med Microbiol. 2004 Oct;294(6):395-9
pubmed: 15595389
Mol Microbiol. 1999 May;32(4):691-701
pubmed: 10361274
Microb Genom. 2021 Nov;7(11):
pubmed: 34739369
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Zentralbl Hyg Umweltmed. 1996 Feb;198(3):241-57
pubmed: 9376053
FEMS Immunol Med Microbiol. 2007 Apr;49(3):337-45
pubmed: 17378897
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Mar;41(3):169-172
pubmed: 36870733
Genes (Basel). 2020 Sep 21;11(9):
pubmed: 32967159
J Infect Chemother. 2008 Feb;14(1):23-9
pubmed: 18297445
Front Microbiol. 2020 Dec 14;11:617685
pubmed: 33381106
Food Microbiol. 2020 Aug;89:103416
pubmed: 32138986
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296
pubmed: 33885785
Antimicrob Agents Chemother. 2011 Aug;55(8):3954-7
pubmed: 21576447
Antimicrob Agents Chemother. 1995 Sep;39(9):1948-53
pubmed: 8540696
Vet Med Sci. 2022 Jul;8(4):1841-1849
pubmed: 35426255
J Appl Microbiol. 2013 Aug;115(2):583-90
pubmed: 23647690
J Appl Microbiol. 2016 Jan;120(1):218-25
pubmed: 26481610
Microb Drug Resist. 2018 Sep;24(7):915-922
pubmed: 29336679
J Med Microbiol. 2017 Dec;66(12):1736-1743
pubmed: 29120301
Infect Immun. 1990 Jan;58(1):55-60
pubmed: 2152889
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13142-7
pubmed: 12271135
FEMS Immunol Med Microbiol. 2008 Nov;54(2):224-35
pubmed: 18754784
Mol Microbiol. 2005 Aug;57(4):1022-35
pubmed: 16091041
Front Microbiol. 2017 Jun 12;8:1060
pubmed: 28659885
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
Appl Environ Microbiol. 2013 Aug;79(16):4951-7
pubmed: 23770897
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Antibiotics (Basel). 2021 Mar 10;10(3):
pubmed: 33802125
Vet Q. 2017 Dec;37(1):136-161
pubmed: 28438095
PLoS One. 2007 Dec 26;2(12):e1358
pubmed: 18159241
Microbiology (Reading). 1998 May;144 ( Pt 5):1205-1211
pubmed: 9611795
J Bacteriol. 2002 May;184(9):2543-5
pubmed: 11948170
Rev Esp Quimioter. 2020 Feb;33(1):73-75
pubmed: 31895525
Genome Biol. 2020 Jul 22;21(1):180
pubmed: 32698896
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31427293
Biochemistry (Mosc). 2005 Feb;70(2):267-74
pubmed: 15807669
Microb Pathog. 2014 Nov;76:19-25
pubmed: 25218724
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417
Perit Dial Int. 2013 Mar-Apr;33(2):222-3
pubmed: 23478380
Wellcome Open Res. 2018 Sep 24;3:124
pubmed: 30345391
Microorganisms. 2023 May 28;11(6):
pubmed: 37374927

Auteurs

Itsaso Baztarrika (I)

MikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain.

Adrián Salazar-Sánchez (A)

MikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain.

Silvia Hernaez Crespo (S)

Bioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.

José Israel López Mirones (JI)

Bioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.

Andrés Canut (A)

Bioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.

Rodrigo Alonso (R)

MikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain.
Bioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.

Ilargi Martínez-Ballesteros (I)

MikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain.
Bioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.

Irati Martinez-Malaxetxebarria (I)

MikroIker Research Group, Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, 01006, Vitoria-d Gasteiz, Spain. irati.martinez@ehu.eus.
Bioaraba, Microbiology, Infectious Diseases, Antimicrobial Agents and Gene Therapy, 01006, Vitoria-Gasteiz, Spain. irati.martinez@ehu.eus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH